Microencapsulation to reduce mechanical loss of microspheres: Implications in myocardial cell therapy

Adil H. Al Kindi, Juan Francisco Asenjo, Yin Ge, Guang Yong Chen, Jasmine Bhathena, Ray C J Chiu, Satya Prakash, Dominique Shum-Tim

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Objective: Previous regenerative studies have demonstrated massive cell losses after intramyocardial cellular delivery. Therefore, efforts at reducing mechanical losses may prove more successful in optimising cellular therapy. In this study, we hypothesized that escalating mesenchymal stem cells (MSCs) dose will not produce corresponding improvement in cardiac function due to washout of the small cells in microcirculation. Using microspheres similar in size to MSCs, that are encapsulated in alginate-poly-l-lysine-alginate (APA), we tested the hypothesis that size is an important factor in early losses. Methods: In experiment I, five groups of rats (n=9 each) underwent coronary ligation; group I had no treatment; the other groups received escalating 0.5×106, 1.5×106, 3×106 and 5×106 of MSCs each. Echocardiogram was performed at baseline, 2 days and 7 weeks after surgery. In experiment II, cell-sized microspheres (10μm) were encapsulated in APA microcapsules. In group I (n=16), rats received bare microspheres, group II (n=16) microspheres within 200μm microcapsules and in group III (n=16), microspheres within 400μm microcapsules. After 20min, hearts were quantified for the amount retained. Results: Myocardial function did not improve further with escalating cell doses beyond an initial response at 1.5×106 cells. Encapsulated microspheres in 200μm and 400μm microcapsules demonstrated a fourfold increase in retention rate compared with 10μm microspheres. Conclusion: We concluded that suboptimal functional improvement in this animal model starts at 1.5×106 cells and does not respond to escalating cell doses. Improving mechanical retention is possible by increasing the size of the injectate. Microencapsulation could be used to encapsulate donor cells and facilitate functional improvement in cellular heart failure therapy.

Original languageEnglish
Pages (from-to)241-247
Number of pages7
JournalEuropean Journal of Cardio-thoracic Surgery
Volume39
Issue number2
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Drug Compounding
Cell- and Tissue-Based Therapy
Microspheres
Capsules
Mesenchymal Stromal Cells
Lysine
Microcirculation
Ligation
Therapeutics
Animal Models
Heart Failure
alginic acid

Keywords

  • Cardiomyoplasty
  • Ischaemia
  • Stem cells
  • Tissue regeneration

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Microencapsulation to reduce mechanical loss of microspheres : Implications in myocardial cell therapy. / Al Kindi, Adil H.; Asenjo, Juan Francisco; Ge, Yin; Chen, Guang Yong; Bhathena, Jasmine; Chiu, Ray C J; Prakash, Satya; Shum-Tim, Dominique.

In: European Journal of Cardio-thoracic Surgery, Vol. 39, No. 2, 02.2011, p. 241-247.

Research output: Contribution to journalArticle

Al Kindi, Adil H. ; Asenjo, Juan Francisco ; Ge, Yin ; Chen, Guang Yong ; Bhathena, Jasmine ; Chiu, Ray C J ; Prakash, Satya ; Shum-Tim, Dominique. / Microencapsulation to reduce mechanical loss of microspheres : Implications in myocardial cell therapy. In: European Journal of Cardio-thoracic Surgery. 2011 ; Vol. 39, No. 2. pp. 241-247.
@article{39bcf0d850f24d5dbd7acbc87bdc3d17,
title = "Microencapsulation to reduce mechanical loss of microspheres: Implications in myocardial cell therapy",
abstract = "Objective: Previous regenerative studies have demonstrated massive cell losses after intramyocardial cellular delivery. Therefore, efforts at reducing mechanical losses may prove more successful in optimising cellular therapy. In this study, we hypothesized that escalating mesenchymal stem cells (MSCs) dose will not produce corresponding improvement in cardiac function due to washout of the small cells in microcirculation. Using microspheres similar in size to MSCs, that are encapsulated in alginate-poly-l-lysine-alginate (APA), we tested the hypothesis that size is an important factor in early losses. Methods: In experiment I, five groups of rats (n=9 each) underwent coronary ligation; group I had no treatment; the other groups received escalating 0.5×106, 1.5×106, 3×106 and 5×106 of MSCs each. Echocardiogram was performed at baseline, 2 days and 7 weeks after surgery. In experiment II, cell-sized microspheres (10μm) were encapsulated in APA microcapsules. In group I (n=16), rats received bare microspheres, group II (n=16) microspheres within 200μm microcapsules and in group III (n=16), microspheres within 400μm microcapsules. After 20min, hearts were quantified for the amount retained. Results: Myocardial function did not improve further with escalating cell doses beyond an initial response at 1.5×106 cells. Encapsulated microspheres in 200μm and 400μm microcapsules demonstrated a fourfold increase in retention rate compared with 10μm microspheres. Conclusion: We concluded that suboptimal functional improvement in this animal model starts at 1.5×106 cells and does not respond to escalating cell doses. Improving mechanical retention is possible by increasing the size of the injectate. Microencapsulation could be used to encapsulate donor cells and facilitate functional improvement in cellular heart failure therapy.",
keywords = "Cardiomyoplasty, Ischaemia, Stem cells, Tissue regeneration",
author = "{Al Kindi}, {Adil H.} and Asenjo, {Juan Francisco} and Yin Ge and Chen, {Guang Yong} and Jasmine Bhathena and Chiu, {Ray C J} and Satya Prakash and Dominique Shum-Tim",
year = "2011",
month = "2",
doi = "10.1016/j.ejcts.2010.03.066",
language = "English",
volume = "39",
pages = "241--247",
journal = "European Journal of Cardio-thoracic Surgery",
issn = "1010-7940",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Microencapsulation to reduce mechanical loss of microspheres

T2 - Implications in myocardial cell therapy

AU - Al Kindi, Adil H.

AU - Asenjo, Juan Francisco

AU - Ge, Yin

AU - Chen, Guang Yong

AU - Bhathena, Jasmine

AU - Chiu, Ray C J

AU - Prakash, Satya

AU - Shum-Tim, Dominique

PY - 2011/2

Y1 - 2011/2

N2 - Objective: Previous regenerative studies have demonstrated massive cell losses after intramyocardial cellular delivery. Therefore, efforts at reducing mechanical losses may prove more successful in optimising cellular therapy. In this study, we hypothesized that escalating mesenchymal stem cells (MSCs) dose will not produce corresponding improvement in cardiac function due to washout of the small cells in microcirculation. Using microspheres similar in size to MSCs, that are encapsulated in alginate-poly-l-lysine-alginate (APA), we tested the hypothesis that size is an important factor in early losses. Methods: In experiment I, five groups of rats (n=9 each) underwent coronary ligation; group I had no treatment; the other groups received escalating 0.5×106, 1.5×106, 3×106 and 5×106 of MSCs each. Echocardiogram was performed at baseline, 2 days and 7 weeks after surgery. In experiment II, cell-sized microspheres (10μm) were encapsulated in APA microcapsules. In group I (n=16), rats received bare microspheres, group II (n=16) microspheres within 200μm microcapsules and in group III (n=16), microspheres within 400μm microcapsules. After 20min, hearts were quantified for the amount retained. Results: Myocardial function did not improve further with escalating cell doses beyond an initial response at 1.5×106 cells. Encapsulated microspheres in 200μm and 400μm microcapsules demonstrated a fourfold increase in retention rate compared with 10μm microspheres. Conclusion: We concluded that suboptimal functional improvement in this animal model starts at 1.5×106 cells and does not respond to escalating cell doses. Improving mechanical retention is possible by increasing the size of the injectate. Microencapsulation could be used to encapsulate donor cells and facilitate functional improvement in cellular heart failure therapy.

AB - Objective: Previous regenerative studies have demonstrated massive cell losses after intramyocardial cellular delivery. Therefore, efforts at reducing mechanical losses may prove more successful in optimising cellular therapy. In this study, we hypothesized that escalating mesenchymal stem cells (MSCs) dose will not produce corresponding improvement in cardiac function due to washout of the small cells in microcirculation. Using microspheres similar in size to MSCs, that are encapsulated in alginate-poly-l-lysine-alginate (APA), we tested the hypothesis that size is an important factor in early losses. Methods: In experiment I, five groups of rats (n=9 each) underwent coronary ligation; group I had no treatment; the other groups received escalating 0.5×106, 1.5×106, 3×106 and 5×106 of MSCs each. Echocardiogram was performed at baseline, 2 days and 7 weeks after surgery. In experiment II, cell-sized microspheres (10μm) were encapsulated in APA microcapsules. In group I (n=16), rats received bare microspheres, group II (n=16) microspheres within 200μm microcapsules and in group III (n=16), microspheres within 400μm microcapsules. After 20min, hearts were quantified for the amount retained. Results: Myocardial function did not improve further with escalating cell doses beyond an initial response at 1.5×106 cells. Encapsulated microspheres in 200μm and 400μm microcapsules demonstrated a fourfold increase in retention rate compared with 10μm microspheres. Conclusion: We concluded that suboptimal functional improvement in this animal model starts at 1.5×106 cells and does not respond to escalating cell doses. Improving mechanical retention is possible by increasing the size of the injectate. Microencapsulation could be used to encapsulate donor cells and facilitate functional improvement in cellular heart failure therapy.

KW - Cardiomyoplasty

KW - Ischaemia

KW - Stem cells

KW - Tissue regeneration

UR - http://www.scopus.com/inward/record.url?scp=78751585117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751585117&partnerID=8YFLogxK

U2 - 10.1016/j.ejcts.2010.03.066

DO - 10.1016/j.ejcts.2010.03.066

M3 - Article

C2 - 20494590

AN - SCOPUS:78751585117

VL - 39

SP - 241

EP - 247

JO - European Journal of Cardio-thoracic Surgery

JF - European Journal of Cardio-thoracic Surgery

SN - 1010-7940

IS - 2

ER -